Assessment of bone turnover by measurement of serum estradiol and interleukin-6
Journal of the Egyptian Public Health Association [The]. 1997; 72 (1-2): 67-86
in English
| IMEMR
| ID: emr-107838
ABSTRACT
This study included twenty-six postmenopausal women and twenty premenopausal ones in a trial to understand how estrogen performs its antiosteoporotic action. Serum estradiol, interleukin 6 [IL-6] and osteocalcin were measured. A highly significant difference in serum estradiol and IL-6 was found between the two groups. It could be concluded that estrogen exerted its antiosteoporotic effect by modulating the production of IL-6, thus inhibiting its stimulatory effect on osteoblasts
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Osteoporosis
/
Bone and Bones
/
Osteocalcin
/
Interleukins
/
Premenopause
/
Estradiol
/
Estrogens
Limits:
Humans
Language:
English
Journal:
J. Egypt. Public Health Assoc.
Year:
1997
Similar
MEDLINE
...
LILACS
LIS